New Boehringer Ingelheim general manager in Denmark wants to draw on experiences from China

British national Steve Wright will also be head of Boehringer Ingelheim’s Danish department, Human Pharma.

Steve Wright is the new general manager of Boehringer Ingelheim Denmark | Photo: Boehringer Ingelheim / PR

Before summer, British National Steve Wright climbed another rung on the career ladder as he was appointed general manager and head of Human Pharma at Boehringer Ingelheim Denmark, where he now leads a team of over 120 employees.

Wright has more than 12 years of experience working at the company, and has also worked for four years at Swiss Novartis and seven at Schering-Plough. Besides his home country of the UK, his career has brought him to Germany and China, and he wants to use experiences from these places on the Danish market.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

FDA fast-tracks Eli Lilly's obesity candidate

Tirzepatide is already approved for type 2 diabetes, and Lilly has been vying for access to the obesity market for a while – the day the drug could be approved in both indications has now been moved up.

Jefferies spots weaknesses in GN

One potential chink in GN’s armor is that the company’s newly announced hearing aid platform, Omnia, isn’t predicted to win significant market shares.

Further reading

Related articles

Latest news

See all jobs